This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
COMT / Catechol O-methyltransferase · IHC design guide
Design Immunohistochemistry for COMT
Plan COMT staining in paraffin sections using the catalog antibody’s IHC conditions and cell-specific tissue controls. The guide covers expected cytoplasmic staining, membrane staining in Bergmann glia, and how to interpret variable intensity (HPA tissue IHC).
Evidence assembled Oct 2026 · For research use; verify linked source records and product datasheet before use
COMT Immunohistochemistry Experimental Design Guide
Expected localisation, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
Must know before staining
| Expected localisation | Variable cytoplasmic staining; membrane staining in Bergmann glia (HPA tissue IHC) | |
| Staining pattern | Variable cytoplasmic staining across tissue cell types (HPA tissue IHC) | |
| Antigen retrieval | Citrate pH 6 HIER, heat-mediated (datasheet M00464) | |
| Positive control | Cerebellum+4 more · see all | |
| Negative control | Adipose tissue+3 more · see all |
Important caveats
Reasons your staining may differ from the expected pattern.
| Fixation | Matched tissue-IHC evidence does not establish the fixation claim. Validate the specimen-specific method before use. (selected-SKU IHC image M00464) | |
| Caveat | Cell-type variation can complicate tissue-level scoring (HPA tissue IHC) | |
| Regulation | Variable expression across tissues (HPA tissue IHC) | |
| Isoform / epitope | 2 isoforms; epitope location may affect detection (UniProt) |
Section 1
Recommended COMT IHC & IF Protocols
The catalog antibody’s IHC-P protocol (datasheet: M00464) appears alongside published COMT staining methods for prostate specimens (PMC8480839) and oral and pharyngeal tissues (PMC8268107).
| Sample | Paraffin-embedded human intestinal cancer tissues; fixative not specified (datasheet M00464) |
| Fixation | Image fixative and duration unreported (datasheet M00464); verify before use. |
| Sectioning | 4–5 µm sections on charged slides (standard) |
| Deparaffinisation | Xylene, graded ethanol series to water (standard) |
| Antigen retrieval | Heat retrieval: Citrate pH 6, 20 min (datasheet M00464) |
| Peroxidase block | 3% H2O2, 10 min, room temperature (standard) |
| Blocking | 10% goat serum (datasheet M00464) |
| Primary antibody | Mouse monoclonal (clone 15C10) anti-COMT, 0.5-1μg/ml (datasheet M00464) |
| Primary incubation | Overnight at 4 °C (datasheet M00464) |
| Detection | Streptavidin-biotin complex (SABC), DAB chromogen (datasheet M00464) |
| Counterstain | Hematoxylin, blue, dehydrate and mount (standard) |
| Expected result | COMT-positive staining in bergmann glia - cytoplasm/membrane of cerebellum (HPA tissue IHC: High). HPA tissue profile: Cytoplasmic expression at variable levels in all tissues. No signal in the no-primary control. |
💡Decision noteStart with heat-mediated citrate retrieval at pH 6 (datasheet: M00464), then optimize staining against tissue background and a positive control (standard IHC practice).
Section 2
What Is the Expected COMT Staining Pattern?
COMT is reported in cytoplasm and at the cell membrane (UniProt P21964 localization). Its membrane-bound isoform has a transmembrane segment at residues 7–26 (UniProt P21964 topology). In tissue IHC, expect variable cytoplasmic staining, including strong staining in Bergmann glia, kidney collecting ducts and placental cytotrophoblasts (HPA tissue IHC). HPA rates the tissue profile Enhanced, while describing only medium consistency with RNA data (HPA tissue IHC).
| Cytoplasmic staining in Bergmann glia, with some membrane staining (HPA tissue IHC). | This matches the reported cerebellar pattern, where Bergmann glia stain High (HPA tissue IHC). Compare the identified cells and compartment before scoring intensity; staining elsewhere in the section does not substitute for that comparison (general IHC interpretation). |
| Predominantly nuclear staining, with little cytoplasmic signal. | A nuclear-only pattern conflicts with the reported tissue distribution and UniProt localization (HPA tissue IHC; UniProt P21964 localization). Check the counterstain and staining controls, then reassess antibody specificity and detection background (general IHC practice). |
| Strong signal in adipocytes or cardiomyocytes. | HPA reports COMT as Not detected in those cell types (HPA tissue IHC). Unexpected staining warrants a cross-reactivity or endogenous detection-activity check (general IHC practice). Do not treat either cell type as a guaranteed blank in every specimen. |
| Color spreads across cells and surrounding tissue without clear boundaries. | A diffuse deposit cannot establish COMT localization (general IHC interpretation). Compare a no-primary control and the expected cell distribution; nonspecific binding or detection background can obscure a genuine cytoplasmic pattern (general IHC practice). |
| No signal in a well-preserved kidney collecting duct or placental cytotrophoblast region. | These are High-staining cell populations in HPA tissue IHC (HPA tissue IHC). First confirm the cell identity and an informative positive control; then assess the antibody, retrieval and detection workflow (general IHC practice). The supplied sources do not establish COMT-specific fixation sensitivity. |
💡Expected COMT appearanceCall a result positive when identifiable Bergmann glia show High cytoplasmic/membrane staining, or collecting ducts or cytotrophoblasts show High staining (HPA tissue IHC); isolated nuclear color or similarly strong adipocyte staining is discordant with the reported pattern (HPA tissue IHC; UniProt P21964 localization).
| Compartment and membrane isoform | UniProt lists cytoplasm and cell membrane and a membrane-bound isoform with a transmembrane segment at residues 7–26 (UniProt P21964). HPA tissue IHC reports variable cytoplasmic expression and cytoplasm/membrane staining in Bergmann glia (HPA tissue IHC). Score the observed compartment in its cell context. |
| Soluble and membrane-bound isoforms | Two isoforms are listed, soluble and membrane-bound (UniProt P21964 isoforms). The record supplies no antibody epitope, so the staining pattern alone cannot establish which isoform was detected. Avoid assigning an isoform from cytoplasmic or membrane color without separate validation. |
| Tissue comparison and evidence strength | HPA reports High staining in collecting ducts and cytotrophoblasts, Medium in melanocytes, and Not detected in adipocytes (HPA tissue IHC). These cell-level comparisons are more informative than treating a whole tissue as uniformly positive or negative. HPA calls the profile Enhanced but notes medium agreement with RNA data (HPA tissue IHC). |
| IF/ICC Q&A: should the same pattern appear? | HPA ICC-IF places COMT mainly in vesicles and additionally in endoplasmic reticulum (HPA subcellular ICC-IF). Those observations come from cells imaged by IF; they do not prescribe a paraffin-section IHC pattern. For IHC, interpret the cytoplasmic and cell-level tissue observations reported by HPA tissue IHC. |
| Situation | Likely cause | Next action |
|---|---|---|
| Known-positive cell population has no chromogenic signal. | The region may lack the expected cells, or the IHC workflow may have failed (general IHC practice). HPA reports High staining in kidney collecting ducts and placental cytotrophoblasts (HPA tissue IHC). | Verify cell identity and section integrity, then review the catalog antibody's IHC-P instructions, retrieval, dilution and detection controls (general IHC practice). Do not infer a COMT-specific fixation effect from these sources. |
| Only nuclei are colored. | That compartment is discordant with cytoplasm/cell membrane localization (UniProt P21964 localization) and HPA's cytoplasmic tissue profile (HPA tissue IHC). | Compare with a no-primary control and inspect the counterstain. Recheck antibody specificity and detection background before assigning COMT positivity (general IHC practice). |
| Adipocytes or cardiomyocytes stain as strongly as the intended positive cells. | Both cell types are reported Not detected in HPA tissue IHC (HPA tissue IHC); cross-reactivity or endogenous detection activity is possible (general IHC practice). | Check a no-primary control and the detection-system controls. Score the unexpected cells separately from nearby positive structures rather than calling the whole section positive (general IHC practice). |
| Diffuse brown color masks cell borders. | Background from nonspecific binding or the detection system can prevent compartment assessment (general IHC practice). | Inspect the no-primary control, blocking and washes; adjust the detection workflow using its validated instructions (general IHC practice). Reassess whether cytoplasmic signal follows identifiable cells. |
| A low-staining population looks negative. | HPA lists low staining in hippocampal glia, thyroid glandular cells and liver cholangiocytes (HPA tissue IHC); weak signal may be hard to distinguish from background. | Compare it with a High-staining population and the negative control under the same scoring criteria (HPA tissue IHC; general IHC practice). Record weak or equivocal staining without upgrading it to High. |
| Punctate IF staining is used to judge the paraffin IHC slide. | HPA ICC-IF reports vesicles and additional endoplasmic reticulum localization (HPA subcellular ICC-IF), while HPA tissue IHC describes variable cytoplasmic staining (HPA tissue IHC). | Score the IHC slide against tissue cell types and compartments documented for IHC (HPA tissue IHC). Use the separate IF/ICC guide when interpreting cellular puncta. |
Experiment evidence
IHC & IF images showing COMT staining
M00464 · IHCIHC analysis of COMT using anti-COMT antibody (M00464). COMT was detected in paraffin-embedded section of human intestinal cancer tissues. H
M00464 · IHCIHC analysis of COMT using anti-COMT antibody (M00464). COMT was detected in paraffin-embedded section of human mammary cancer tissues. Heat
M00464 · IFIF analysis of COMT using anti-COMT antibody (M00464). COMT was detected in immunocytochemical section of A431 cell. Enzyme antigen retrieva
PB9539 · IHCIHC analysis of COMT using anti-COMT antibody (PB9539). COMT was detected in paraffin-embedded section of Mouse Lung Tissue. Heat mediated a
PB9539 · IHCIHC analysis of COMT using anti-COMT antibody (PB9539). COMT was detected in paraffin-embedded section of Rat Lung Tissue. Heat mediated ant
HPA · Cerebral cortexHuman Protein Atlas IHC, Cerebral cortex. Source: https://www.proteinatlas.org/ENSG00000093010-COMT/tissue/cerebral+cortex#imid_2979604
HPA · ColonHuman Protein Atlas IHC, Colon. Source: https://www.proteinatlas.org/ENSG00000093010-COMT/tissue/colon#imid_2979514
HPA · LiverHuman Protein Atlas IHC, Liver. Source: https://www.proteinatlas.org/ENSG00000093010-COMT/tissue/liver#imid_2979531
HPA · KidneyHuman Protein Atlas IHC, Kidney. Source: https://www.proteinatlas.org/ENSG00000093010-COMT/tissue/kidney#imid_2979524
HPA · ICC-IF A-431Human Protein Atlas immunofluorescence, A-431, antibody HPA001169; green = COMT, blue = nucleus, red = microtubules.
HPA · ICC-IF A-431Human Protein Atlas immunofluorescence, A-431, antibody HPA001169; green = COMT, blue = nucleus, red = microtubules.
← swipe / scroll for more images →
Real IHC / IF data behind the staining-pattern expectations in this section.
Sample controls for COMT IHC & IF
🧪Run kidney first: collecting duct cells should stain strongly (HPA: High in collecting ducts). Use skeletal muscle myocytes as a negative tissue (HPA: Not detected in myocytes); within the kidney section, cells that lack specific staining should show counterstain without DAB deposition, but do not assume every non-collecting duct cell is COMT-negative.
Positive control tissue: Cerebellum (Bergmann glia - cytoplasm/membrane, HPA High)
Negative control tissue: Adipose tissue (HPA Not detected)
ICC-IF cell lines (HPA subcellular resource): HPA ICC-IF images show COMT in A-431, U-251MG, U2OS, HeLa BAC 5885, HeLa , with annotated localisation: Vesicles (enhanced) (HPA subcellular).
Technical controls: Include a no-primary, secondary-only control and an isotype control matched to the mouse primary antibody’s immunoglobulin class (caption: mouse anti-COMT antibody M00464). If available, use COMT-knockout tissue as a biological negative; block endogenous peroxidase and assess endogenous biotin background in kidney when using the caption’s biotin-based SABC/DAB detection (caption: SABC with DAB).
⚠️Feasibility: A target-specific fixation window or fixation effect is unreported, and the selected M00464 tissue-IHC caption does not state its fixative (caption: fixative not stated). Heat retrieval in citrate buffer at pH 6 for 20 minutes is documented for a paraffin-embedded intestinal cancer section, so its performance in kidney needs verification (caption: citrate retrieval for 20 minutes). No supplied matched protocol establishes that frozen sections or IF are easier; with the caption’s biotin-based detection, check renal tubules for endogenous biotin background (caption: SABC with DAB; standard IHC practice).
HPA tissue IHC evidence for COMT
Comprehensive Human Protein Atlas IHC scoring per tissue (reliability: Enhanced — Medium consistency between antibody staining and RNA expression data. Paired antibodies with high similarity supports the protein expression profile.). Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
Positive expression · recommended positive controls
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Cerebellum | Bergmann glia - cytoplasm/membrane | High | Protein (IHC) | HPA → |
| Epididymis | Glandular cells | High | Protein (IHC) | HPA → |
| Kidney | Collecting ducts | High | Protein (IHC) | HPA → |
| Placenta | Cytotrophoblasts | High | Protein (IHC) | HPA → |
| Skin | Melanocytes | Medium | Protein (IHC) | HPA → |
Undetected expression · recommended negative controls
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | Adipocytes | Not detected | Protein (IHC) | HPA → |
| Heart muscle | Cardiomyocytes | Not detected | Protein (IHC) | HPA → |
| Skeletal muscle | Myocytes | Not detected | Protein (IHC) | HPA → |
| Vagina | Squamous epithelial cells | Not detected | Protein (IHC) | HPA → |
Section 3
Advanced COMT IHC Tips
Use compartment, cell type, and control staining together when optimizing COMT chromogenic IHC in paraffin sections (UniProt P21964; HPA tissue IHC).
How should I retrieve COMT in paraffin sections when staining is weak?
Start with heat-mediated citrate buffer at pH 6 for 20 minutes (datasheet M00464). The selected paraffin-section image used that retrieval, followed by 10% goat-serum blocking and 1 µg/mL primary antibody overnight at 4°C (datasheet M00464). If staining remains weak, compare a slightly longer heating time on adjacent sections while holding antibody concentration, detection, and development constant; excessive heating can damage morphology (standard IHC practice). Include a collecting-duct-rich kidney section as a positive reference and cardiomyocytes as a low-signal comparison, assessing the specified cells rather than whole-section color (HPA tissue IHC).
Could fixation explain weak or patchy COMT staining?
Target-specific COMT fixation sensitivity is unknown: the selected paraffin-section caption does not state its fixative (datasheet M00464). Record fixative, time before fixation, fixation duration, processing schedule, and section age before comparing specimens, because each can alter morphology or antigen accessibility in routine IHC (standard IHC practice). If feasible, stain adjacent sections from differently processed material together using citrate pH 6 retrieval for 20 minutes, the documented starting condition (datasheet M00464). Evaluate staining alongside tissue preservation and a positive reference; do not attribute a weak result to a COMT-specific fixation effect without a direct processing comparison (standard IHC practice).
Which staining compartments should I expect for COMT?
Expect predominantly cytoplasmic tissue staining, with membrane staining possible in some cells (HPA tissue IHC; UniProt P21964 subcellular location). COMT has membrane-bound and soluble isoforms, and its annotated membrane segment spans residues 7–26; these annotations support checking both compartments without requiring identical patterns across tissues (UniProt P21964 isoforms and topology). In HPA images, Bergmann glia show high cytoplasmic or membrane signal, while collecting ducts and cytotrophoblasts show high staining in their listed cell populations (HPA tissue IHC). Score compartment and cell identity separately, and review a hematoxylin counterstain when apparent membrane rims may reflect crowded cell borders (standard IHC practice).
Can this stain distinguish membrane-bound from soluble COMT?
Do not assign an isoform from DAB distribution alone: COMT has membrane-bound and soluble isoforms, while this caption provides no epitope map or isoform-selectivity result for M00464 (UniProt P21964 isoforms; datasheet M00464). The annotated transmembrane segment is residues 7–26, with residues 27–271 annotated extracellular in the membrane topology; that annotation alone cannot establish which residues the antibody recognizes (UniProt P21964 topology). Phosphoserine at residue 267 is annotated, but phospho-specific recognition has not been established here (UniProt P21964 modified residues; datasheet M00464). Request an epitope or isoform validation result before making an isoform-specific claim, and report compartment-level staining meanwhile (standard IHC interpretation).
How can I check COMT localisation by multiplex IF?
For a separate IF experiment, pair COMT with a validated marker of the expected cell population, such as a cytotrophoblast marker in placenta, and confirm cell identity in the merged image (HPA tissue IHC; standard IF practice). Select a far-red COMT fluorophore when tissue autofluorescence affects shorter wavelengths, and inspect single-label and no-primary controls before interpreting overlap (standard IF practice). Because COMT is annotated in cytoplasm and cell membrane, compare staining with and without mild detergent permeabilisation when epitope access is uncertain; the membrane isoform’s annotated residues 27–271 are extracellular (UniProt P21964 subcellular location and topology; standard IF practice). The catalog caption establishes paraffin-section IHC conditions, not an IF dilution or fixation condition (datasheet M00464).
What should I change when COMT DAB staining is diffuse?
First compare a no-primary section with the complete detection sequence; DAB signal there indicates detection-system or endogenous-enzyme background rather than demonstrated COMT binding (standard IHC practice). The documented IHC sequence uses biotinylated goat anti-mouse secondary antibody, a streptavidin-biotin complex, and DAB, so include appropriate peroxidase and endogenous-biotin controls when those components produce background (datasheet M00464; standard IHC practice). Recheck the 10% goat-serum block and 1 µg/mL primary starting concentration before changing one variable at a time (datasheet M00464). Reject staining confined to folds, section edges, or damaged areas, and compare intact cells with a reference section stained in the same run (standard IHC practice).
How should I score COMT across paraffin specimens? ⚠ ANSWER MARKED FOR VERIFICATION
Define the cell population and compartment before scoring, because reported COMT tissue staining is variable and mainly cytoplasmic (HPA tissue IHC). Within matched regions, record percent positive cells and intensity for an H-score, or positive-cell density per mm² when cell abundance differs; apply identical thresholds and imaging settings across specimens (standard IHC quantification practice). Normalize cell-based scores to the number of evaluable cells in the specified population, or area-based counts to viable tissue area, excluding necrosis and section artefacts (standard IHC quantification practice). Report cytoplasmic and membrane results separately, with a positive reference and no-primary control for each staining run (UniProt P21964 subcellular location; standard IHC practice).
How do I distinguish convincing COMT signal from artefact?
A convincing result follows a plausible compartment and identified cell population: COMT is annotated in cytoplasm and cell membrane, and HPA reports high signal in collecting ducts and cytotrophoblasts (UniProt P21964 subcellular location; HPA tissue IHC). Unexpected nuclear-only color, staining restricted to an edge or necrotic region, or signal in a no-primary control warrants review before calling cells positive (standard IHC practice). Endogenous peroxidase or biotin can complicate interpretation of the caption’s DAB and streptavidin-biotin detection sequence, so inspect the corresponding controls (datasheet M00464; standard IHC practice). Compare with HPA’s listed cardiomyocytes, where COMT was not detected, while judging matched cell types and section quality (HPA tissue IHC; standard IHC practice).
Boster reagents
Best COMT / Catechol O-methyltransferase IHC Antibodies
Anti-COMT IHC images cover human cancer and placenta sections and mouse and rat lung sections (catalog IHC captions); IF images cover A431 and MCF7 cells (M00464 IF captions).
Real IHC data
Anti-COMT Antibody ® (monoclonal, 15C10)
Cat # M00464
Real IHC data
Anti-COMT Antibody ®
Cat # PB9539
M00464 will render with a human intestinal cancer paraffin-section IHC image; its catalog also documents human mammary cancer and placenta IHC and A431 and MCF7 IF (M00464 image captions). PB9539 will render with a mouse lung paraffin-section IHC image; its catalog also documents rat lung and human placenta IHC (PB9539 image captions).
Which to pick: For human tissue IHC, M00464 is a monoclonal option with human paraffin-section images (M00464 catalog and IHC captions). For IHC across species, PB9539 has human, mouse, and rat reactivity and paraffin-section images from each (PB9539 catalog and IHC captions); the captions do not report a fixative. For IF/ICC, choose M00464 because IF and ICC are listed applications with cell images, while PB9539 has no listed IF application (catalog applications; M00464 IF captions).
Each figure is that product's own IHC / IF validation image from its datasheet.
References
- UniProt Consortium. UniProt entry P21964 (COMT_HUMAN, Catechol O-methyltransferase).
- Human Protein Atlas. COMT tissue IHC expression (reliability: Enhanced).
- Human Protein Atlas. COMT subcellular location (ICC-IF): Localized to vesicles. In addition localized to the endoplasmic reticulum..
- Human Protein Atlas. COMT antibody validation summary (2 antibodies).
- Suppressor effect of catechol-O-methyltransferase gene in prostate cancer. PloS one 2021 — PMC8480839.
- Genetic variation in COMT activity impacts learning and dopamine release capacity in the striatum. Learning & memory (Cold Spring Harbor, N.Y.) 2014 — PMC3966542.
- Catechol-O-methyltransferase (COMT) protein expression and activity after dopaminergic and noradrenergic lesions of the rat brain. PloS one 2013 — PMC3628796.
- Genetic and Proteinic Linkage of MAO and COMT with Oral Potentially Malignant Disorders and Cancers of the Oral Cavity and Pharynx. Cancers 2021 — PMC8268107.
- PubMed PMID:1707278 — UniProt-cited evidence.
- PubMed PMID:1847521 — UniProt-cited evidence.
- PubMed PMID:8055944 — UniProt-cited evidence.
Immunohistochemistry protocol sheet for COMT (Catechol O-methyltransferase). Expected localisation Variable cytoplasmic staining; membrane staining in Bergmann glia (HPA tissue IHC). Antigen retrieval: Citrate pH 6 HIER, heat-mediated (datasheet M00464). Validated IHC antibody: M00464 at 0.5-1μg/ml (the product's own IHC validation image is shown). Controls (HPA): positive Cerebellum (Bergmann glia - cytoplasm/membrane); negative Adipose tissue. IHC-P workflow on paraffin sections; fixative unspecified. Protocol steps: 1. Sample: Paraffin-embedded human intestinal cancer tissues; fixative not specified (datasheet M00464); 2. Fixation: Image fixative and duration unreported (datasheet M00464); verify before use.; 3. Sectioning: 4–5 µm sections on charged slides (standard); 4. Deparaffinisation: Xylene, graded ethanol series to water (standard); 5. Antigen retrieval: Heat retrieval: Citrate pH 6 , 20 min (datasheet M00464); 6. Peroxidase block: 3% H2O2, 10 min , room temperature (standard); 7. Blocking: 10% goat serum (datasheet M00464); 8. Primary antibody: Mouse monoclonal (clone 15C10) anti-COMT, 0.5-1μg/ml (datasheet M00464); 9. Primary incubation: Overnight at 4 °C (datasheet M00464). Watch for: Fixation: Matched tissue-IHC evidence does not establish the fixation claim. Validate the specimen-specific method before use. (selected-SKU IHC image M00464); Caveat: Cell-type variation can complicate tissue-level scoring (HPA tissue IHC); Isoform / epitope: 2 isoforms; epitope location may affect detection (UniProt); Regulation: Variable expression across tissues (HPA tissue IHC). Evidence: UniProt P21964, HPA tissue IHC · Enhanced, HPA ICC-IF · vesicles. In addition localized to the endoplasmic reticulum., Datasheet M00464, PMC8480839, PMC8268107. QR code links to https://www.bosterbio.com/bosterbio-gene-info-cards/COMT/immunohistochemistry-ihc-guide.